Expression of 1,25-Dihydroxyvitamin D3 Receptors in Normal and Psoriatic Skin
- 1 August 1991
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 97 (2) , 230-239
- https://doi.org/10.1111/1523-1747.ep12480255
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- 1,25-dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor bindingCellular Immunology, 1990
- Towards a better definition of human leucocyte surface moleculesImmunology Today, 1989
- The immunobiology ofvitamin D: William F.C. RigbyImmunology Today, 1988
- Vitamin D, its Precursors, and Metabolites do not Affect Melanization of Cultured Human MelanocytesJournal of Investigative Dermatology, 1988
- Immunologic mechanisms in psoriasisJournal of the American Academy of Dermatology, 1988
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Possible Functions of 1α,25-Dihydroxyvitamin D3, an Active Form of Vitamin D3, in the Differentiation and Development of SkinJournal of Investigative Dermatology, 1985
- γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophagesBiochemical and Biophysical Research Communications, 1985
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Abnormal Cell Proliferation in Psoriasis**From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida.Journal of Investigative Dermatology, 1968